The Ames Salmonella /Microsome Mutagenicity Assay: Issues of Inference and Validation
Ames 沙门氏菌/微粒体致突变试验:推断与验证AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要讨论生物试验中的非标准检验与尺寸验证,没有充分证据对应所列经济计量领域细分。
Ames 沙门氏菌/微粒体致突变试验:推断与验证AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
The importance of chemically induced mutation for human health is discussed briefly, and the biological basis for the primary in vitro assay for mutagenicity, the Ames Salmonella/microsome assay, is reviewed. A previous analysis for Ames test data, based on two mathematical models of the competing risks of mutation and toxicity, is shown to have inflated false-positive rates. A reason for this is the existence of local singularities in the Fisher information matrix. A new likelihood ratio test incorporating a pretest of a nuisance parameter is proposed, and its size is validated with replicated experimental data through an analysis based on a finite-mixture-of-binomials model.